Concepedia
Statistics
Publications
8
Citations
452
H-Index
Active since
1992
Affiliations
Bayer (Germany)(Current)
Heidelberg University
German Cancer Research Center
Target (Germany)
R. Kast is an author at Bayer (Germany) specializing in pharmacology, medicine, and molecular pharmacology.
Publications per year
1992–2012
Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT<sub>2</sub>) receptor
Frank Wunder, Hanna Tinel, R. Kast et al. · British Journal of Pharmacology · 2010 · 76 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +13
Activation of cytosolic phospholipase A2 by transforming growth factor-alpha in HEL-30 keratinocytes
R. Kast, Gerhard Fürstenberger, Friedrich Marks · Journal of Biological Chemistry · 1993 · 74 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +14
Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling
Stephan Schäfer, Peter Ellinghaus, Wiebke Janssen et al. · Cardiovascular Research · 2009 · 70 citations · Full text
Medicine, Cardiology, Pharmacology +17
Cardiovascular effects of a novel potent and highly selective azaindole‐based inhibitor of Rho‐kinase
R. Kast, Hartmut Schirok, Santiago Figueroa‐Pérez et al. · British Journal of Pharmacology · 2007 · 65 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +14
Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension
Bhola K. Dahal, Djuro Kosanovic, Pavan Kumar Pamarthi et al. · European Respiratory Journal · 2010 · 52 citations · Full text
1–5 of 8